Inventor
LYSSIKATOS JOSEPH P
US115 patents
⚠️ This page may combine multiple inventors who share the name “LYSSIKATOS JOSEPH P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARRAY BIOPHARMA INC
17 patentsUS7732616B2Jun 8, 2010
Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC35 citations96
US7517994B2Apr 14, 2009
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC36 citations96
US7449486B2Nov 11, 2008
Mitotic kinesin inhibitors and methods of use thereof
ARRAY BIOPHARMA INC37 citations96
US7425637B2Sep 16, 2008
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC27 citations96
US7235537B2Jun 26, 2007
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC53 citations96
US7777050B2Aug 17, 2010
N3 alkylated benzimidazole derivatives as MEK inhibitors
ARRAY BIOPHARMA INC13 citations92
US7598383B2Oct 6, 2009
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC19 citations92
US9693989B2Jul 4, 2017
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
ARRAY BIOPHARMA INC13 citations91
US7956073B2Jun 7, 2011
Mitotic kinesin inhibitors and methods of use thereof
ARRAY BIOPHARMA INC8 citations84
US7893065B2Feb 22, 2011
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC14 citations84
US7576072B2Aug 18, 2009
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC9 citations84
US7511058B2Mar 31, 2009
Heterocyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC8 citations84
US7485643B2Feb 3, 2009
Bicyclic inhibitors of MEK and methods of use thereof
ARRAY BIOPHARMA INC9 citations84
US9221841B2Dec 29, 2015
Mitotic kinesin inhibitors and methods of use thereof
ARRAY BIOPHARMA INC5 citations83
US7795282B2Sep 14, 2010
Mitotic kinesin inhibitors and methods of use thereof
ARRAY BIOPHARMA INC9 citations83
US7491829B2Feb 17, 2009
RAF inhibitor compounds and methods
ARRAY BIOPHARMA INC17 citations83
US10780073B2Sep 22, 2020
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
ARRAY BIOPHARMA INC7 citations82
PFIZER
11 patentsUS6071935AJun 6, 2000
Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors
PFIZER106 citations98
US6150377ANov 21, 2000
Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
PFIZER56 citations95
US7019147B1Mar 28, 2006
Benzimidazole derivatives useful as antiproliferative agents
PFIZER47 citations92
US6579887B2Jun 17, 2003
Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
PFIZER18 citations92
US6495564B1Dec 17, 2002
Quinolin-2-one derivatives useful as anticancer agents
PFIZER37 citations92
US6294552B1Sep 25, 2001
Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
PFIZER15 citations92
US6194438B1Feb 27, 2001
Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one, and compositions and methods for inhibiting abnormal cell growth comprising said derivatives
PFIZER46 citations92
US6080769AJun 27, 2000
Imidazolidin-4-one derivatives useful as anticancer agents
PFIZER34 citations92
US6734308B2May 11, 2004
Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3,- dihydroxybutanedioate salts and method of production
PFIZER15 citations90
US6043238AMar 28, 2000
2-Aminobenzazapine derivatives
PFIZER37 citations89
US7071337B2Jul 4, 2006
Benzoimidazole derivatives useful as antiproliferative agents
PFIZER36 citations87
BIOGEN MA INC
5 patentsUS9809577B2Nov 7, 2017
Biaryl inhibitors of Bruton's tyrosine kinase
BIOGEN MA INC12 citations92
US10227341B2Mar 12, 2019
Inhibiting agents for bruton's tyrosine kinase
BIOGEN MA INC8 citations83
US10081619B2Sep 25, 2018
Biaryl inhibitors of bruton's tyrosine kinase
BIOGEN MA INC7 citations83
US10961237B2Mar 30, 2021
Inhibiting agents for Bruton's tyrosine kinase
BIOGEN MA INC4 citations82
US10189829B2Jan 29, 2019
Inhibiting agents for Bruton's tyrosine kinase
BIOGEN MA INC6 citations82
DENALI THERAPEUTICS INC
4 patentsUS9815850B2Nov 14, 2017
Compounds, compositions and methods
DENALI THERAPEUTICS INC36 citations97
US9932325B2Apr 3, 2018
Compounds, compositions, and methods
DENALI THERAPEUTICS INC16 citations92
US11111235B2Sep 7, 2021
Compounds, compositions, and methods
DENALI THERAPEUTICS INC7 citations84
US10590114B2Mar 17, 2020
Compounds, compositions, and methods
DENALI THERAPEUTICS INC5 citations84
HANS JEREMY
4 patentsUS8623895B2Jan 7, 2014
Mitotic kinesin inhibitors and methods of use thereof
HANS JEREMY4 citations83
US8236825B2Aug 7, 2012
Mitotic kinesin inhibitors and methods of use thereof
HANS JEREMY7 citations83
US8268871B2Sep 18, 2012
Mitotic kinesin inhibitors and methods of use thereof
HANS JEREMY7 citations82
US8580828B2Nov 12, 2013
Mitotic kinesin inhibitors and methods of use thereof
HANS JEREMY5 citations81
GENENTECH INC
2 patentsBLAKE JAMES F
2 patentsLYSSIKATOS JOSEPH P
1 patentBERGERON PHILIPPE
1 patentWALLACE ELI M
1 patentHOWBERT JAMES JEFFRY
1 patentZHU BING-YAN
1 patentShowing the top 50 of 115 patents by PatentIndex Score.